Quantitative Systematic Strategies LLC Chemo Centryx, Inc. Transaction History

Quantitative Systematic Strategies LLC

$0
Q3 2022

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 06, 2021	SELL	$49.53 - $68.4 $176,623 - $243,914	-3,566 Reduced 17.13%	17,249 $884,000
Q4 2020 Feb 09, 2021	BUY	$47.25 - $65.16 $90,672 - $125,042	1,919 Added 10.16%	20,815 $1.29 Million
Q3 2020 Nov 09, 2020	BUY	$46.35 - $61.69 $90,428 - $120,357	1,951 Added 11.51%	18,896 $1.04 Million
Q2 2020 Aug 04, 2020	BUY	$38.58 - $65.07 $89,891 - $151,613	2,330 Added 15.94%	16,945 $975,000
Q1 2020 May 06, 2020	BUY	$32.73 - $50.78 $478,348 - $742,149	14,615 New	14,615 $587,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.